FR2326183A1 - Composes et compositions a activite antiallergique et antianaphylactique - Google Patents

Composes et compositions a activite antiallergique et antianaphylactique

Info

Publication number
FR2326183A1
FR2326183A1 FR7629467A FR7629467A FR2326183A1 FR 2326183 A1 FR2326183 A1 FR 2326183A1 FR 7629467 A FR7629467 A FR 7629467A FR 7629467 A FR7629467 A FR 7629467A FR 2326183 A1 FR2326183 A1 FR 2326183A1
Authority
FR
France
Prior art keywords
antiallergic
compositions
compounds
antianaphylactic
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7629467A
Other languages
English (en)
Inventor
Leif Ake Svensson
Lars Magnus Sorenby
Kjell Ingvar Leopold Wetterli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of FR2326183A1 publication Critical patent/FR2326183A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR7629467A 1975-10-01 1976-09-30 Composes et compositions a activite antiallergique et antianaphylactique Withdrawn FR2326183A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
FR2326183A1 true FR2326183A1 (fr) 1977-04-29

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7629467A Withdrawn FR2326183A1 (fr) 1975-10-01 1976-09-30 Composes et compositions a activite antiallergique et antianaphylactique

Country Status (19)

Country Link
JP (1) JPS5242840A (fr)
AT (1) AT347427B (fr)
AU (1) AU503212B2 (fr)
BE (1) BE846837A (fr)
CS (2) CS199644B2 (fr)
DD (1) DD126278A5 (fr)
DE (1) DE2640972A1 (fr)
DK (1) DK141622B (fr)
ES (1) ES451979A1 (fr)
FI (1) FI762660A (fr)
FR (1) FR2326183A1 (fr)
GB (1) GB1542317A (fr)
LU (1) LU75916A1 (fr)
NL (1) NL7610845A (fr)
NO (1) NO763345L (fr)
NZ (1) NZ182165A (fr)
SE (1) SE7510988L (fr)
SU (2) SU638252A3 (fr)
ZA (1) ZA765331B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (fr) 1980-07-09 1984-05-30 Aktiebolaget Draco Dérivés du 1-(dihydroxyphényl)-2-amino éthanol; préparation, compositions et intermédiaires
EP0103830A3 (fr) * 1982-09-22 1985-07-31 Bayer Ag Dérivés de phényléthylamine comme stimulateurs de croissance
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
EP2471779A1 (fr) 2006-04-03 2012-07-04 Arena Pharmaceuticals, Inc. Procédé de résolution d'un mélange de (R)- et (S)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1H-3-benzazépine
WO2008070111A2 (fr) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Procédés de préparation de (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazépine et intermédiaires de celle-ci
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법
CA3050049A1 (fr) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Formes galeniques a liberation modifiee d'agonistes de 5-ht2c, utiles pour la gestion du poids
AU2011296033A1 (en) 2010-09-01 2013-04-04 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
WO2012030939A1 (fr) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration de lorcasérine à des individus présentant une insuffisance rénale
AR088670A1 (es) 2012-10-09 2014-06-25 Arena Pharm Inc Metodo de control del peso

Also Published As

Publication number Publication date
AT347427B (de) 1978-12-27
GB1542317A (en) 1979-03-14
DK141622B (da) 1980-05-12
CS199643B2 (en) 1980-07-31
SE7510988L (sv) 1977-04-02
FI762660A (fr) 1977-04-02
DK439776A (fr) 1977-04-02
ES451979A1 (es) 1978-01-01
NO763345L (fr) 1977-04-04
AU1812276A (en) 1978-04-06
BE846837A (fr) 1977-04-01
DD126278A5 (fr) 1977-07-06
SU674669A3 (ru) 1979-07-15
NL7610845A (nl) 1977-04-05
ZA765331B (en) 1977-08-31
LU75916A1 (fr) 1978-05-16
NZ182165A (en) 1978-07-10
SU638252A3 (ru) 1978-12-15
DE2640972A1 (de) 1977-04-14
ATA682376A (de) 1978-05-15
AU503212B2 (en) 1979-08-30
CS199644B2 (en) 1980-07-31
JPS5242840A (en) 1977-04-04

Similar Documents

Publication Publication Date Title
FR2300552A1 (fr) Composes hypolipidemiants
FR2316201A1 (fr) Similigranite et sa preparation
AU1934876A (en) Hydroxybenzylmalonic acid derivatives
MC1101A1 (fr) Composition a activite retardee
NZ184352A (en) Monic acid esters and their preparation
JPS53103477A (en) Benzoic acid derivative and its production
US6048977C1 (en) Clavulanic acid and salts thereof
SE7606951L (sv) Imidyl-bensendi- och trikarbonsyra-derivat
SE393030B (sv) Hopsettbar leksaksfigur
FR2329270A1 (fr) Nouveaux composes a activite anti-fertilite
FR2326183A1 (fr) Composes et compositions a activite antiallergique et antianaphylactique
ZA774737B (en) Novel azolyl-carboxylic acid derivatives and their use as fungicides
HK44980A (en) Hydroxybenzylmalonic acid derivatives
AU506250B2 (en) Clavulanic acid derivatives
BE840904A (fr) Composes anorectiques
NZ182021A (en) Phenoxyalkylcarboxylic acid derivatives and pharmaceuticalcompositions
IL50657A (en) 11-deoxy-16-aryl- -tetranor-prosta-cis-5-ene-13-yneoic acid derivatives and their preparation
GB1554299A (en) Phenylacetic acid derivatives
BE828690A (fr) Composes a activite anti-allergique
FR2293204A1 (fr) 6-methylergolines 8,8-disubstituees et composes apparentes
KE3292A (en) Clavulanic acid derivatives
JPS5268186A (en) Picolinic acid derivatives and their preparation
ZA773348B (en) Azido-and amino-clavulanic acid and derivatives
ZA774528B (en) Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
IL52492A0 (en) Novel 5-furoyl-and 5-thenoyl-pyrrolopyrole-1-carboxylic acid derivatives their production and pharmaceuticalcompositionscontaining them

Legal Events

Date Code Title Description
ST Notification of lapse